Back

Expansion Revealing of Pathology Resolves Nanostructures Associated with Inflammatory Phenotypes in COVID-19 Decedent Human Brain Tissue

Stanton, A. E.; Kang, J.; Blanchard, J. W.; Boix, C. A.; Schroeder, M. E.; Lee, Y.; Su, H.; Wang, S.; Yu, E.; Emenari, A.; Peng, Z.; Agbas, E.; Cerit, O.; Park, D.; Zhang, R.; Bennett, D. A.; Yin, P.; Kellis, M.; Langer, R.; Boyden, E.; Tsai, L.-H.

2026-05-15 neuroscience
10.64898/2026.05.14.725177 bioRxiv
Show abstract

Expansion revealing (ExR) elucidates cellular organization by separating proteins within dense nanostructures by 20x linear expansion, but requires fixation procedures incompatible with human pathology specimens. Here, we report ExR of pathology (ExRPath), which attains [~]20 nm resolution and decrowding of such tissues, through iterative 20x expansion, adapted to human brain pathology specimens. We also report a single-shot 15x expansion protocol for such tissues (15ExMPath), achieved through one-shot 15x expansion. Applying ExRPath and 15ExMPath to COVID-19-decedent brain tissue reveals periodic amyloid nanoclusters that co-localize with SARS-CoV-2 in a rare minority of patient specimens, pointing to a potential neuroinflammatory phenotype associated with COVID-19, and highlighting the power of high-throughput nanoimaging, empowered by expansion microscopy, for discovering potential novel disease mechanisms.

Matching journals

The top 4 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.